Medical Devices Ordinance
(MedDO)

English is not an official language of the Swiss Confederation. This translation is provided for information purposes only and has no legal force.

of 1 July 2020 (Status as of 26 May 2021)


Open article in different language:  DE  |  FR  |  IT
Art. 61 Content

1 The safety re­port must con­tain:

a.
a sum­mary of the res­ults and con­clu­sions of the ana­lyses of the post-mar­ket sur­veil­lance data gathered as a res­ult of the post-mar­ket sur­veil­lance plan as spe­cified in Art­icle 58;
b.
a ra­tionale and de­scrip­tion of any pre­vent­ive and cor­rect­ive ac­tions taken.

2 Throughout the life­time of the device con­cerned, the safety re­port must set out:

a.
the con­clu­sions of the be­ne­fit-risk de­term­in­a­tion;
b.
the key res­ults of post-mar­ket clin­ic­al fol­low-up;
c.
the total sales volume of the device;
d.
an es­tim­ate of the size of the pop­u­la­tion us­ing the device;
e.
char­ac­ter­ist­ics of the pop­u­la­tion in let­ter d;
f.
the fre­quency of device us­age, where prac­tic­able.

3 The safety re­port forms part of the tech­nic­al doc­u­ment­a­tion spe­cified in An­nexes II and III to EU-MDR73. For cus­tom-made devices, the re­port forms part of the doc­u­ment­a­tion spe­cified in Sec­tion 2 of An­nex XIII to EU-MDR.

73 See the foot­note to Art. 4 para. 1 let. f.

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback
Laden